Back
Evans Bancorp Vs. Rhythm Pharmaceuticals Industry Stock Comparison
Buy
53
EVBN
Evans Bancorp
Last Price:
$38.78
Seasonality Move:
-0.58%
Buy
63
RYTM
Rhythm Pharmaceuticals
Last Price:
$63.69
Seasonality Move:
15.42%
Buy
53
Evans Bancorp (EVBN)
is a Buy
Is Evans Bancorp a Buy, Sell or Hold?
-
The current Evans Bancorp [EVBN] share price is $38.70. The Score for EVBN is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
-
EVBN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
63
Rhythm Pharmaceuticals (RYTM)
is a Buy
Is Rhythm Pharmaceuticals a Buy, Sell or Hold?
-
The current Rhythm Pharmaceuticals [RYTM] share price is $63.76. The Score for RYTM is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
-
RYTM is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
EVBN Stock Price Chart
What is Evans Bancorp's stock price today?
-
The Evans Bancorp share price today is $38.70The current trend is relatively stagnant and EVBN is experiencing slight selling pressure.
RYTM Stock Price Chart
What is Rhythm Pharmaceuticals's stock price today?
-
The Rhythm Pharmaceuticals share price today is $63.76Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RYTM is experiencing buying pressure, which is a positive indicator for future bullish movement.
EVBN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.42 | Sell |
Relative Strength Index (14 RSI): | 56.91 | Buy |
Chaikin Money Flow: | -2736 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (35.57 - 39.03) | Buy |
Bollinger Bands (100): | (38.57 - 44.59) | Sell |
RYTM Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.28 | Buy |
Relative Strength Index (14 RSI): | 63.66 | Buy |
Chaikin Money Flow: | 369446 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (52.02 - 61.16) | Buy |
Bollinger Bands (100): | (53.03 - 59.91) | Buy |
EVBN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 37.09 | Buy |
20-day SMA: | 36.77 | Buy |
50-day SMA: | 39.47 | Sell |
200-day SMA: | 39.31 | Sell |
8-day EMA: | 37.46 | Buy |
20-day EMA: | 37.35 | Buy |
50-day EMA: | 38.86 | Sell |
200-day EMA: | 38.5 | Buy |
RYTM Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 61.43 | Buy |
20-day SMA: | 57.42 | Buy |
50-day SMA: | 55.27 | Buy |
200-day SMA: | 53.46 | Buy |
8-day EMA: | 61.16 | Buy |
20-day EMA: | 58.64 | Buy |
50-day EMA: | 56.64 | Buy |
200-day EMA: | 52.62 | Buy |
Evans Bancorp Earnings Growth & EVBN Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.31 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.69 per share, and a decrease next year of $0.00 per share.
Rhythm Pharmaceuticals Earnings Growth & RYTM Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.26 per share, an increase next quarter of $0.07 per share, an increase this year of $1.54 per share, and an increase next year of $1.14 per share.
Evans Bancorp Technical Analysis
Apr 11 | Apr 14 | Apr 15 | Apr 16 | Apr 17 | Apr 21 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
11 | 14 | 15 | 16 | 17 | 21 | 22 | 23 | 24 | 25 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Rhythm Pharmaceuticals Technical Analysis
Apr 11 | Apr 14 | Apr 15 | Apr 16 | Apr 17 | Apr 21 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
11 | 14 | 15 | 16 | 17 | 21 | 22 | 23 | 24 | 25 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |